Home PharmTech Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

by Newsroom


Darmstadt, Germany – November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos – stock.adobe.com

Merck KGaA (Merck), headquartered in Darmstadt, Germany, and Israel-based Peregrine Ventures have announced a collaboration agreement in which Merck will become a strategic partner in one of Peregrine Ventures’ dedicated investment vehicles, called the Incentive Incubator (1,2). Peregrine is a global specialist in investments in transformative medical technologies. Merck, meanwhile, employs approximately 63,000 people in 65 countries.

A press release issued about the launch of the…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC